The stock of Craneware plc (LON:CRW) is a huge mover today! The stock increased 0.78% or GBX 9 on November 10, hitting GBX 1165. About 19,492 shares traded hands. Craneware plc (LON:CRW) has risen 43.83% since April 13, 2016 and is uptrending. It has outperformed by 38.18% the S&P500.
The move comes after 6 months negative chart setup for the GBX 316.22 million company. It was reported on Nov, 10 by Barchart.com. We have GBX 1013.55 PT which if reached, will make LON:CRW worth GBX 41.11M less.
Craneware plc (LON:CRW) Ratings Coverage
Out of 3 analysts covering Craneware (LON:CRW), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Craneware has been the topic of 17 analyst reports since July 16, 2015 according to StockzIntelligence Inc. As per Wednesday, July 6, the company rating was maintained by Peel Hunt. The rating was maintained by Investec with “Buy” on Friday, January 22. Peel Hunt maintained it with “Buy” rating and GBX 920 target price in Thursday, April 28 report. Investec maintained it with “Buy” rating and GBX 750 target price in Tuesday, September 8 report. Peel Hunt maintained Craneware plc (LON:CRW) rating on Tuesday, September 6. Peel Hunt has “Buy” rating and GBX 1335 price target. On Thursday, November 10 the stock rating was maintained by Peel Hunt with “Buy”. The stock of Craneware plc (LON:CRW) has “Buy” rating given on Wednesday, July 13 by Peel Hunt. The firm earned “Buy” rating on Monday, March 14 by Peel Hunt. The stock of Craneware plc (LON:CRW) has “Buy” rating given on Tuesday, March 8 by Investec. On Thursday, August 25 the stock rating was maintained by Peel Hunt with “Buy”.
More news for Craneware plc (LON:CRW) were recently published by: Prnewswire.com, which released: “Craneware Announces Year-End Financial Results for Fiscal Year 2015” on September 08, 2015. Prnewswire.com‘s article titled: “Craneware Announces Year-End Financial Results for Fiscal Year 2016” and published on September 06, 2016 is yet another important article.
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The company has a market cap of 316.22 million GBP. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention. It has a 37.07 P/E ratio. The Company’s Patient Engagement solutions include InSight Medical Necessity, Trisus Patient Payment and Patient Charge Estimator.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.